UA83094C2 - Tablet of citalopram hydrobromide - Google Patents

Tablet of citalopram hydrobromide

Info

Publication number
UA83094C2
UA83094C2 UAA200607053A UAA200607053A UA83094C2 UA 83094 C2 UA83094 C2 UA 83094C2 UA A200607053 A UAA200607053 A UA A200607053A UA A200607053 A UAA200607053 A UA A200607053A UA 83094 C2 UA83094 C2 UA 83094C2
Authority
UA
Ukraine
Prior art keywords
tablet
citalopram hydrobromide
tablets
preparation
particle size
Prior art date
Application number
UAA200607053A
Other languages
Russian (ru)
Inventor
Паль Фекете
Сильвия Фейкус
Селль Жужа Славине
Original Assignee
Эгиш Дьедьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьедьсердьяр Рт. filed Critical Эгиш Дьедьсердьяр Рт.
Publication of UA83094C2 publication Critical patent/UA83094C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to tablets and film-coated tablets containing as active ingredient citalopram hydrobromide having a median particle size of less than 40 pm in admixture with microcrystalline cellulose having a median particle size in the range of 90 250 urn and other excipients conventionally applied for the preparation of tablets 1 he invention also provides a process for the preparation thereof.
UAA200607053A 2003-11-25 2004-11-24 Tablet of citalopram hydrobromide UA83094C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0303790A HU227491B1 (en) 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide

Publications (1)

Publication Number Publication Date
UA83094C2 true UA83094C2 (en) 2008-06-10

Family

ID=89981808

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200607053A UA83094C2 (en) 2003-11-25 2004-11-24 Tablet of citalopram hydrobromide

Country Status (9)

Country Link
EP (1) EP1694321A1 (en)
BG (1) BG109587A (en)
CZ (1) CZ2006376A3 (en)
EA (1) EA010290B1 (en)
HU (1) HU227491B1 (en)
PL (1) PL379864A1 (en)
SK (1) SK50532006A3 (en)
UA (1) UA83094C2 (en)
WO (1) WO2005051374A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
IS6021A (en) * 2000-08-10 2001-10-20 H. Lundbeck A/S Pharmaceutical formulations containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.

Also Published As

Publication number Publication date
HU227491B1 (en) 2011-07-28
HUP0303790A3 (en) 2005-09-28
HU0303790D0 (en) 2004-03-01
WO2005051374A1 (en) 2005-06-09
BG109587A (en) 2006-12-29
PL379864A1 (en) 2006-11-27
CZ2006376A3 (en) 2006-10-11
EA010290B1 (en) 2008-08-29
EA200600932A1 (en) 2006-10-27
EP1694321A1 (en) 2006-08-30
SK50532006A3 (en) 2006-09-07
HUP0303790A2 (en) 2005-08-29

Similar Documents

Publication Publication Date Title
HK1073263A1 (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
CA2322315A1 (en) Fast disintegrating tablets
MY125766A (en) Flash-melt oral dosage formulation
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
FI20011852A (en) A process for the preparation of a dispersible tablet containing fluoxetine or an acid addition salt thereof
MX2007008679A (en) Direct compression formulation and process.
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
CA2489407A1 (en) Lasofoxifene tablet and its coating
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
MY127350A (en) Flash-melt oral dose formulations
EA201001108A1 (en) TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING
WO2003059329A3 (en) Polytartrate composition
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
NO20054417L (en) Process for the preparation of pharmaceutical preparations in the form of fibrate-containing tablets and the tablets thus prepared
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
WO2004000265A3 (en) Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
UA89349C2 (en) Uncoated tablet containing olanzapine and a process for preparing thereof
UA83094C2 (en) Tablet of citalopram hydrobromide
BG108686A (en) Cytisine-containing medicamentous form
LT2004062A (en) Amlodipine bezylate tablets with improved stability
BRPI0211439B8 (en)